Chris King

Chris King is an experienced professional in the real world evidence and healthcare solutions sectors, currently serving as Senior Director, Client Partner at Aetion since May 2024. Prior to this role, Chris held various positions at IQVIA from April 2018 to October 2023, including Global Category Leader for Therapy Areas where responsibility included driving growth in oncology, rare diseases, and CNS-focused offerings. Chris also served as Real World Solutions Principal, providing strategic advice on Real World Evidence generation for global pharmaceutical clients. Earlier roles include Principal and Head of Real World Evidence Solutions in China and South East Asia at IMS Health Asia Pacific, as well as Oncology Head and Strategic Solutions roles at IMS Health. Chris holds an MBA from London Business School, obtained between January 2005 and January 2007.